Financial reports
10-K
2023 FY
Annual report
1 Apr 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
31 Mar 22
Current reports
8-K
Departure of Directors or Certain Officers
14 Mar 24
8-K
Departure of Directors or Certain Officers
11 Jan 24
8-K
Other Events
27 Dec 23
8-K
Other Events
21 Mar 23
8-K
HealthLynked Announces Appointment of Paul J. Hobaica, MD to its Board of Directors
15 Mar 23
8-K
HealthLynked Announces Sale of ACO Health Partners
23 Jan 23
8-K
Entry into a Material Definitive Agreement
18 Nov 22
8-K
Departure of Directors or Certain Officers
19 Oct 22
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
22 Jul 22
8-K
Entry into a Material Definitive Agreement
8 Jul 22
Registration and prospectus
S-1
IPO registration
11 Jul 22
S-8
Registration of securities for employees
13 Oct 21
424B5
Prospectus supplement for primary offering
30 Aug 21
S-3
Shelf registration
20 Apr 21
424B3
Prospectus supplement
12 Jun 20
POS AM
Prospectus update (post-effective amendment)
29 May 20
POS AM
Prospectus update (post-effective amendment)
22 May 20
POS AM
Prospectus update (post-effective amendment)
20 Jun 19
POS AM
Prospectus update (post-effective amendment)
17 Jun 19
424B3
Prospectus supplement
23 Aug 18
Other
EFFECT
Notice of effectiveness
20 Jul 22
UPLOAD
Letter from SEC
15 Jul 22
CORRESP
Correspondence with SEC
15 Jul 22
UPLOAD
Letter from SEC
15 Jul 22
CORRESP
Correspondence with SEC
1 Jun 22
UPLOAD
Letter from SEC
25 May 22
EFFECT
Notice of effectiveness
27 Apr 21
CORRESP
Correspondence with SEC
22 Apr 21
UPLOAD
Letter from SEC
21 Apr 21
EFFECT
Notice of effectiveness
2 Jun 20